Physician profile
Patricia L Kropf
NPI 1497957112
$122,278.53
in general payments reported to CMS, 2019-2025
11 companies · $43K in 2025
The $43K reported for 2025 was more than what 93% of Hematology (Internal Medicine) providers received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,116 · 2023: $28K · 2024: $46K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $86K · Consulting Fee: $15K · Travel and Lodging: $14K · Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $86,277.00 |
| Consulting Fee | $15,192.50 |
| Travel and Lodging | $14,330.32 |
| Food and Beverage | $1,362.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $48,476.98 | 2022-2025 | Iclusig, Ninlaro |
| Glaxosmithkline, LLC. | $30,447.99 | 2024-2025 | Ojjaara |
| Incyte Corporation | $28,672.85 | 2023-2025 | Jakafi, Jakafi |
| E.R. Squibb & Sons, L.L.C. | $5,676.00 | 2022-2025 | |
| Syndax Pharmaceuticals, INC. | $3,865.89 | 2025 | Revuforj |
| Sanofi-Aventis U.S. LLC | $3,038.82 | 2025 | |
| Servier Pharmaceuticals LLC | $2,100.00 | 2023 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Kropf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.